NASDAQ:LIFE
aTyr Pharma Stock News
$1.62
+0.0300 (+1.89%)
At Close: Apr 18, 2024
aTyr Pharma Announces Poster Presentation at the Society for Immunotherapy of Cancer Annual Meeting
08:01am, Friday, 01'st Oct 2021
SAN DIEGO, Oct. 01, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological path
aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
04:01pm, Thursday, 16'th Sep 2021
SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pat
aTyr Pharma Announces Proposed Public Offering of Common Stock
04:01pm, Wednesday, 15'th Sep 2021
SAN DIEGO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotherapeutics company engaged in the discovery and development of innovative medicines based on novel
aTyr (LIFE) Surges on Positive Data on Lead Candidate ATYR1923
12:59pm, Tuesday, 14'th Sep 2021
aTyr Pharma (LIFE) soars following the announcement of positive results from its phase Ib/IIa study of its lead candidate, ATYR1923, for pulmonary sarcoidosis.
LIFE Stock: 7 Things to Know About Biotech aTyr Pharma as Shares Soar on Study Results
12:42pm, Tuesday, 14'th Sep 2021
Atyr Pharma (LIFE) stock is soaring higher on Tuesday after the company released positive data from a recent clinical trial. The post LIFE Stock: 7 Things to Know About Biotech aTyr Pharma as Shares S
Why aTyr Pharma Shares Are Continuing To Surge Higher Today
12:05pm, Tuesday, 14'th Sep 2021
aTyr Pharma Inc (NASDAQ: LIFE) is trading significantly higher Tuesday after multiple analyst firms maintained bullish ratings on the stock and raised their respective price targets following the com
A small pharmaceutical company has surged 137% in 2 days after positive results in trials for lung disease treatment
12:03pm, Tuesday, 14'th Sep 2021
aTyr says it plans to meet with the FDA to present its data on ATYR1923, a potential treatment for pulmonary sarcoidosis.
Why Did Wainwright Beef Up ATyr Pharma's Price Target?
03:24pm, Monday, 13'th Sep 2021
H.C. Wainwright increased the price target on ATyr Pharma (NASDAQ:LIFE) to $18 from $13, with the Buy rating unchanged, implying more than 120% upside. Today, the Company reported positive data fr
LIFE Stock: Why It Significantly Increased Today
01:05pm, Monday, 13'th Sep 2021
The stock price of aTyr Pharma Inc (NASDAQ: LIFE) significantly increased today. This is why it happened.
LIFE Stock: What Is the Clinical Trial News Sending aTyr Pharma Soaring?
01:04pm, Monday, 13'th Sep 2021
Today, some news of positive clinical trial results for one of aTry's leading drug candidates has sent LIFE stock surging. The post LIFE Stock: What Is the Clinical Trial News Sending aTyr Pharma Soar
Why Are ATyr Pharma's Shares Trading Higher Today?
09:52am, Monday, 13'th Sep 2021
ATyr Pharma Inc (NASDAQ: LIFE) has announced positive results from its Phase 1b/2a trial evaluating its lead therapeutic candidate, ATYR1923, in pulmonary sarcoidosis, a major form of interstitial lun
Trial met primary endpoint, ATYR1923 was safe and well-tolerated.
aTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q2 2021 Results - Earnings Call Transcript
10:06pm, Tuesday, 10'th Aug 2021
aTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q2 2021 Results - Earnings Call Transcript
Atyr Pharma (LIFE) Reports Q2 Loss, Lags Revenue Estimates
06:33pm, Tuesday, 10'th Aug 2021
Atyr Pharma (LIFE) delivered earnings and revenue surprises of -39.13% and -100.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
aTyr Pharma: Q2 Earnings Insights
04:28pm, Tuesday, 10'th Aug 2021
Shares of aTyr Pharma (NASDAQ:LIFE) fell in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 7.25% over the past year to ($0.64), which missed
